InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,641.60
(
0.83%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
87.25
(
0.39%
)
Bitcoin
58,164.27
(
-3.32%
)
Post# of 346044
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

senrex

Send PM Follow Ignore
Followers 7
Posts 444
Boards Moderated 0
Alias Born 01/22/2006

senrex

Re: md1225 post# 106169

Friday, 01/04/2013 7:11:43 AM

Friday, January 04, 2013 7:11:43 AM

Post# of 346044
md1225 said: "As Ive stated before the CODING DISCREPANCIES were between which patient received which bavi dose 1mg or 3mg in a subset of patients..."

I don't doubt an ounce of your veracity. What puzzles me is if that was the only problem, why the statement on that fateful morning in September when management said that investors should not rely on their prior comments regarding their lung cancer results? If it was just a question of dosage -- and not of results -- why the crisis tone of that press release?

Also, if IR replied to someone on this Board that the reviewing process should be a matter of weeks and not months, what is holding up those results?

Just trying to understand.

TIA.
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CDMO News
More CDMO News
InvestorsHub NewsWire

Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM

EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM

BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM

NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM

Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM

VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM

Start posting your company's news
Only $200 per official company press release!